Fig. 3From: Symptoms and quality of life among men starting treatment for metastatic castration-resistant prostate cancer – a prospective multicenter study(a) MSAS-PHYS subscale dimension scores, (b) MSAS-PSYCH subscale dimension scores (c) dimension scores for symptoms from the MSAS not present in PHYS or PSYCH subscalesBack to article page